O	0	2	No
O	3	9	effect
O	10	12	of
B-intervention	13	21	exercise
O	22	24	on
O	25	32	insulin
O	32	33	-
O	33	37	like
O	38	44	growth
O	45	51	factor
O	51	52	-
O	52	53	I
O	53	54	,
O	55	62	insulin
O	62	63	,
O	64	67	and
O	68	75	glucose
O	76	78	in
O	79	84	young
O	85	90	women
O	91	104	participating
O	105	107	in
O	108	109	a
O	110	112	16
O	112	113	-
O	113	117	week
O	118	128	randomized
O	129	139	controlled
O	140	145	trial
O	145	146	.

O	147	154	Insulin
O	154	155	-
O	155	159	like
O	160	166	growth
O	167	173	factor
O	174	175	I
O	176	177	(
O	177	180	IGF
O	180	181	-
O	181	182	I
O	182	183	)
O	184	187	and
O	188	191	IGF
O	192	199	binding
O	200	207	protein
O	208	209	3
O	210	211	(
O	211	216	IGFBP
O	216	217	-
O	217	218	3
O	218	219	)
O	220	224	have
O	225	229	been
O	230	240	associated
O	241	245	with
O	246	255	increased
O	256	260	risk
O	261	263	of
O	264	270	breast
O	271	277	cancer
O	277	278	.

O	279	281	We
O	282	288	report
O	289	292	our
O	293	301	findings
O	302	304	on
O	305	308	the
O	309	316	effects
O	317	319	of
O	320	322	16
O	323	328	weeks
O	329	331	of
O	332	339	aerobic
O	340	348	exercise
O	349	351	on
O	352	355	IGF
O	356	360	axis
O	361	369	proteins
O	369	370	,
O	371	378	insulin
O	378	379	,
O	380	387	glucose
O	387	388	,
O	389	392	and
O	393	400	insulin
O	401	411	resistance
O	412	414	of
B-total-participants	415	418	319
B-eligibility	419	424	young
I-eligibility	425	434	sedentary
I-eligibility	435	440	women
O	440	441	.

O	442	454	Demographics
O	454	455	,
O	456	462	health
O	463	470	surveys
O	470	471	,
O	472	476	body
O	477	488	composition
O	488	489	,
O	490	497	dietary
O	498	504	intake
O	504	505	,
O	506	509	and
O	510	515	blood
O	516	523	samples
O	524	528	were
O	529	538	collected
O	539	541	at
O	542	550	baseline
O	551	554	and
O	555	557	16
O	558	563	weeks
O	563	564	.

O	565	568	IGF
O	568	569	-
O	569	570	I
O	571	574	and
O	575	580	IGFBP
O	580	581	-
O	581	582	1
O	582	583	,
O	584	589	IGFBP
O	589	590	-
O	590	591	2
O	591	592	,
O	593	596	and
O	597	602	IGFBP
O	602	603	-
O	603	604	3
O	605	609	were
O	610	618	measured
O	619	621	by
O	622	627	ELISA
O	627	628	.

B-outcome	629	637	Exercise
I-outcome	638	647	adherence
O	648	651	was
O	652	654	88
O	654	655	%
O	655	656	.

O	657	660	The
B-outcome	661	668	dropout
I-outcome	669	674	rates
O	675	678	for
O	679	682	the
O	683	691	exercise
O	692	695	and
B-control	696	703	control
I-control	704	710	groups
O	711	715	were
B-iv-bin-percent	716	718	21
I-iv-bin-percent	718	719	.
I-iv-bin-percent	719	720	7
I-iv-bin-percent	720	721	%
O	722	725	and
B-cv-bin-percent	726	728	14
I-cv-bin-percent	728	729	.
I-cv-bin-percent	729	730	5
I-cv-bin-percent	730	731	%
O	731	732	,
O	733	745	respectively
O	745	746	.

O	747	752	There
O	753	756	was
O	757	758	a
O	759	764	small
O	765	776	significant
B-outcome	777	783	change
I-outcome	784	788	from
I-outcome	789	797	baseline
I-outcome	798	800	in
I-outcome	801	806	IGFBP
I-outcome	806	807	-
I-outcome	807	808	3
I-outcome	809	823	concentrations
O	823	824	.

B-outcome	825	830	IGFBP
I-outcome	830	831	-
I-outcome	831	832	3
I-outcome	833	839	levels
O	840	849	decreased
O	850	852	in
O	853	861	controls
O	862	865	and
O	866	875	increased
O	876	878	in
O	879	889	exercisers
O	889	890	.

O	891	894	The
O	895	902	between
O	902	903	-
O	903	908	group
O	909	919	difference
O	920	923	was
O	924	935	significant
O	935	936	.

O	937	939	No
O	940	945	other
O	946	953	changes
O	954	958	were
O	959	964	noted
O	964	965	.

O	966	973	Sixteen
O	974	979	weeks
O	980	982	of
O	983	991	exercise
O	992	995	had
O	996	1003	minimum
O	1004	1006	or
O	1007	1009	no
B-outcome	1010	1016	effect
I-outcome	1017	1019	on
I-outcome	1020	1023	IGF
I-outcome	1024	1032	proteins
O	1033	1035	of
O	1036	1041	young
O	1042	1047	women
O	1047	1048	.

O	1049	1052	Our
O	1053	1058	study
O	1059	1067	supports
O	1068	1076	findings
O	1077	1081	from
O	1082	1090	previous
O	1091	1098	studies
O	1099	1108	conducted
O	1109	1111	in
O	1112	1117	older
O	1118	1129	populations
O	1130	1133	and
O	1134	1140	raises
O	1141	1144	the
O	1145	1153	question
O	1154	1156	of
O	1157	1161	what
O	1162	1166	type
O	1167	1169	of
O	1170	1182	intervention
O	1183	1185	is
O	1186	1192	needed
O	1193	1195	to
O	1196	1202	change
O	1203	1214	circulating
O	1215	1221	levels
O	1222	1224	of
O	1225	1228	IGF
O	1229	1237	proteins
O	1238	1240	in
O	1241	1247	humans
O	1247	1248	.
